<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04579302</url>
  </required_header>
  <id_info>
    <org_study_id>AP2007-50105</org_study_id>
    <nct_id>NCT04579302</nct_id>
  </id_info>
  <brief_title>Serratus Anterior Block and Erector Spinae Block in Postoperative Analgesia</brief_title>
  <official_title>Evaluation of the Effect of Serratus Anterior Block and Erector Spinae Block on Postoperative Analgesia in Thoracic Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus&#xD;
      anterior block and erector spinae block and control group. during anaesthesia:total&#xD;
      intraoperative fentanyl required will be recorded. After surgery, all patients will be&#xD;
      connected to PCA device containing morphine solution, the amount of morphine consumed during&#xD;
      the first 24 hours will be recorded.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus&#xD;
      anterior block (SAB) and erector spinae block (ESB) and control group. During anaesthesia:&#xD;
      total intraoperative fentanyl required will be recorded. After surgery, all patients will be&#xD;
      connected to PCA device containing morphine solution, the amount of morphine consumed during&#xD;
      the first 24 hours will be recorded. Other secondary outcomes are: numerical rating scales&#xD;
      and postoperative pulmonary functions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total morphine consumption in first postoperative 24 hours</measure>
    <time_frame>first 24 postoperative hours</time_frame>
    <description>the amount of morphine required to relieve pain will be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraoperative fentanyl requirement</measure>
    <time_frame>during anaesthesia</time_frame>
    <description>the amount of fentanyl required during anaesthesia will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>numerical rating scale</measure>
    <time_frame>the first 24 postoperative hours</time_frame>
    <description>numerical rating scale (from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain) will be recorded in different time intervals during the first 24 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulmonary functions</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>FVC and FEV1 will be recorded at 24 hours after surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Postoperative Analgesia</condition>
  <arm_group>
    <arm_group_label>serratus anterior block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>serratus anterior block with 20 ml bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>erector spinae block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>erector spinae block with 20 ml bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham block with 20 ml saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Serratus anterior block (SAB)</intervention_name>
    <description>Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5%</description>
    <arm_group_label>serratus anterior block</arm_group_label>
    <other_name>SAB group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae block</intervention_name>
    <description>Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5%</description>
    <arm_group_label>erector spinae block</arm_group_label>
    <other_name>ESB group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline (as a placebo)</intervention_name>
    <description>Patients will receive a sham block with 20 ml saline (as a placebo)</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>bupivacaine</description>
    <arm_group_label>erector spinae block</arm_group_label>
    <arm_group_label>serratus anterior block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with class II physical status (American Society of Anaesthesiologists) ,&#xD;
&#xD;
          -  Age between 18-70 years,&#xD;
&#xD;
          -  Scheduled for thoracic cancer surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Local infection at the site of the block.&#xD;
&#xD;
          -  Cardiac dysfunction (ejection fraction &lt;45%).&#xD;
&#xD;
          -  Significant respiratory disorders.&#xD;
&#xD;
          -  Preexisting neurological or psychiatric disease.&#xD;
&#xD;
          -  Allergy to one of the study drugs.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed E Hassan, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute - Vairo University - Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 24, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Serratus anterior block</keyword>
  <keyword>Erector spinae block</keyword>
  <keyword>Postoperative analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

